Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices

被引：11

作者：

Dhruva, Sanket S. ^{[1
,2
,3
]}

Mazure, Carolyn M. ^{[4
,5
]}

Ross, Joseph S. ^{[1
,6
,7
,8
]}

Redberg, Rita F. ^{[9
,10
]}

机构：

[1] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, 333 Cedar St,SHM I-456,POB 208088, New Haven, CT 06520 USA

[2] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA

[3] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA

[4] Yale Sch Med, Dept Psychiat, New Haven, CT USA

[5] Yale Sch Med, Womens Hlth Res Yale, New Haven, CT USA

[6] Yale Sch Med, Gen Internal Med Sect, Dept Internal Med, New Haven, CT USA

[7] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA

[8] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA

[9] Univ Calif San Francisco, Dept Med, Div Cardiol, Sch Med, San Francisco, CA 94143 USA

[10] Univ Calif San Francisco, Sch Med, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA

来源：

JAMA INTERNAL MEDICINE | 2017年 / 177卷 / 09期

关键词：

D O I：

10.1001/jamainternmed.2017.3148

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1390 / 1391

页数：3

共 50 条

[41] Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration
Michelle B. Nadler
Brooke E. Wilson
Alexandra Desnoyers
Consolacion Molto Valiente
Ramy R. Saleh
Eitan Amir
[J]. Scientific Reports, 14
[42] The US Food and Drug Administration's Approach for Safe Innovation of Medical Devices in Dermatology
Chang, Cynthia J.
Ashar, Binita S.
Marquart, Laura N.
[J]. JAMA DERMATOLOGY, 2018, 154 (03) : 261 - 263
[43] Primer on medical device regulation .2. Regulation of medical devices by the US Food and Drug Administration
Monsein, LH
[J]. RADIOLOGY, 1997, 205 (01) : 10 - 18
[44] Magnitude of clinical benefit of randomized controlled trials supporting US Food and Drug Administration approval of drugs for solid tumours
Molto Valiente, C.
Amir, E.
Fernandez, A. Ocana
Templeton, A.
del Carpio Huerta, L.
Del Paggio, J.
Barnadas, A.
Booth, C.
Tibau, A.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[45] Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016
Ladanie, Aviv
Schmitt, Andreas M.
Speich, Benjamin
Naudet, Florian
Agarwal, Arnav
Pereira, Tiago V.
Sclafani, Francesco
Herbrand, Amanda K.
Briel, Matthias
Martin-Liberal, Juan
Schmid, Thomas
Ewald, Hannah
Ioannidis, John P. A.
Bucher, Heiner C.
Kasenda, Benjamin
Hemkens, Lars G.
[J]. JAMA NETWORK OPEN, 2020, 3 (11) : E2024406
[46] Evaluation of Representation of Women As Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Hematological Drugs
Farooq, Muhammad Zain
Sohail, Aruba
Fatima, Areej
Jawed, Areesha
Jaglal, Michael
[J]. BLOOD, 2022, 140 : 10775 - 10776
[47] Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017
Zhang, Audrey D.
Puthumana, Jeremy
Downing, Nicholas S.
Shah, Nilay D.
Krumholz, Harlan M.
Ross, Joseph S.
[J]. JAMA NETWORK OPEN, 2020, 3 (04)
[48] Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
Shahid, Izza
Khan, Muhammad Shahzeb
Sohail, Aruba
Khan, Safi U.
Greene, Stephen J.
Fudim, Marat
Michos, Erin D.
[J]. JAMA NETWORK OPEN, 2022, 5 (02)
[49] Inclusion of Comparative Effectiveness Data in High-Risk Cardiovascular Device Studies at the Time of Premarket Approval
Chen, Connie E.
Dhruva, Sanket S.
Redberg, Rita F.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (17): : 1740 - 1742
[50] US Food and Drug Administration medical device review and approval; Myths, misconceptions, realities, and potential policy changes
Wallner, Paul E.
Sandler, Howard M.
[J]. PRACTICAL RADIATION ONCOLOGY, 2014, 4 (06) : 472 - 478

← 1 2 3 4 5 →